A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure
Not Applicable
Completed
- Conditions
- Diabetes
- Interventions
- Device: LIFELEAF Smartwatch
- Registration Number
- NCT05904769
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this research is to compare blood glucose, blood pressure and electrocardiogram (ECG) readings on the LIFELEAF Smartwatch compared to standard methods of measurement.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 87
Inclusion Criteria
- Diabetic patients on insulin undergoing four times daily blood sugar checks as part of standard of care.
- Patients undergoing continuous monitoring for heart rate and blood pressure as part of their routine care.
- Patients undergoing catheter ablation for atrial fibrillation.
Read More
Exclusion Criteria
- Patients unable to provide informed consent.
- Patients without arms as these are needed to wear the wrist-based sensor.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Electrophysiologic (EP) Group LIFELEAF Smartwatch Subjects undergoing an EP procedure will wear he LIFELEAF Smartwatch for the duration of the procedure. Hospitalized Diabetic Group LIFELEAF Smartwatch Subjects hospitalized and diabetic on insulin, undergoing four times daily blood sugar checks, will wear the LIFELEAF Smartwatch for the duration of their hospital stay.
- Primary Outcome Measures
Name Time Method Systolic blood pressure Baseline Measured in millimeters of mercury (mmHg)
Diastolic blood pressure Baseline Measured in millimeters of mercury (mmHg)
Blood glucose level Baseline Measured in milligrams per deciliter (mg/dL)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic Minnesota
🇺🇸Rochester, Minnesota, United States